Hiroyoshi Doi

696 total citations
19 papers, 429 citations indexed

About

Hiroyoshi Doi is a scholar working on Hepatology, Immunology and Epidemiology. According to data from OpenAlex, Hiroyoshi Doi has authored 19 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 9 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Hiroyoshi Doi's work include Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Immunotherapy and Immune Responses (5 papers). Hiroyoshi Doi is often cited by papers focused on Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Immunotherapy and Immune Responses (5 papers). Hiroyoshi Doi collaborates with scholars based in Japan and United States. Hiroyoshi Doi's co-authors include David E. Kaplan, Tatsuya Kanto, Shiroh Tanoue, Junichi Eguchi, Michio Imawari, Kazumasa Hiroishi, Masashi Sakaki, Hong Li, Kyong‐Mi Chang and Takayoshi Ito and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Scientific Reports.

In The Last Decade

Hiroyoshi Doi

19 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyoshi Doi Japan 10 206 189 166 99 56 19 429
Arjan Boltjes Netherlands 8 163 0.8× 191 1.0× 320 1.9× 54 0.5× 103 1.8× 20 537
Amir Gander United Kingdom 8 108 0.5× 147 0.8× 340 2.0× 123 1.2× 37 0.7× 14 522
Ahmed Eid Israel 9 200 1.0× 156 0.8× 120 0.7× 56 0.6× 56 1.0× 22 433
Tsuneaki Tagaya Japan 6 184 0.9× 172 0.9× 80 0.5× 69 0.7× 85 1.5× 7 353
Kiyoshi Furuta Japan 11 219 1.1× 228 1.2× 79 0.5× 76 0.8× 75 1.3× 28 469
Hideko Nuriya Japan 11 151 0.7× 177 0.9× 163 1.0× 36 0.4× 131 2.3× 14 423
Shijun Chen China 11 111 0.5× 165 0.9× 137 0.8× 40 0.4× 141 2.5× 20 400
Sarah Goddard United Kingdom 6 100 0.5× 87 0.5× 264 1.6× 87 0.9× 50 0.9× 12 411
Michelle Chung United States 6 167 0.8× 193 1.0× 145 0.9× 45 0.5× 129 2.3× 9 458
Yuejiao Dong China 11 81 0.4× 166 0.9× 138 0.8× 74 0.7× 46 0.8× 24 323

Countries citing papers authored by Hiroyoshi Doi

Since Specialization
Citations

This map shows the geographic impact of Hiroyoshi Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyoshi Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyoshi Doi more than expected).

Fields of papers citing papers by Hiroyoshi Doi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyoshi Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyoshi Doi. The network helps show where Hiroyoshi Doi may publish in the future.

Co-authorship network of co-authors of Hiroyoshi Doi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyoshi Doi. A scholar is included among the top collaborators of Hiroyoshi Doi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyoshi Doi. Hiroyoshi Doi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Doi, Hiroyoshi & Tatsuya Kanto. (2021). Factors influencing the durability of hepatitis B vaccine responses. Vaccine. 39(36). 5224–5230. 16 indexed citations
2.
Doi, Hiroyoshi, Sachiyo Yoshio, Hironari Kawai, et al.. (2019). Immune Determinants in the Acquisition and Maintenance of Antibody to Hepatitis B Surface Antigen in Adults After First‐Time Hepatitis B Vaccination. Hepatology Communications. 3(6). 812–824. 8 indexed citations
3.
Shimagaki, Tomonari, Sachiyo Yoshio, Hironari Kawai, et al.. (2019). Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma. Scientific Reports. 9(1). 15788–15788. 22 indexed citations
4.
5.
Shimagaki, Tomonari, Sachiyo Yoshio, Hironari Kawai, et al.. (2019). Serum Milk Fat Globule-EGF Factor 8 (MFG-E8) As a Diagnostic and Prognostic Biomarker in Patients with Hepatocellular Carcinoma. SSRN Electronic Journal. 1 indexed citations
6.
Yoshio, Sachiyo, Yohei Mano, Hiroyoshi Doi, et al.. (2018). Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients. JCI Insight. 3(20). 30 indexed citations
7.
Doi, Hiroyoshi, Eiichi Hayashi, Jun Arai, et al.. (2018). Enhanced B‐cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia. Journal of Gastroenterology and Hepatology. 33(9). 1667–1676. 17 indexed citations
8.
Osawa, Yosuke, Yukiko Hayashi, Masamichi Kimura, et al.. (2018). Tumor necrosis factor‐α‐mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice. Hepatology Communications. 2(4). 407–420. 29 indexed citations
9.
Shoji, Hirotaka, Sachiyo Yoshio, Yohei Mano, et al.. (2017). Pro‐angiogenic TIE‐2‐expressing monocytes/TEMs as a biomarker of the effect of sorafenib in patients with advanced hepatocellular carcinoma. International Journal of Cancer. 141(5). 1011–1017. 6 indexed citations
10.
Doi, Hiroyoshi, Shiroh Tanoue, & David E. Kaplan. (2013). Peripheral CD27−CD21− B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clinical Immunology. 150(2). 184–191. 49 indexed citations
11.
Eguchi, Junichi, Kazumasa Hiroishi, Masashi Sakaki, et al.. (2012). Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors. Cancer Gene Therapy. 19(9). 637–643. 15 indexed citations
12.
Doi, Hiroyoshi, Erica L. Carpenter, Hong Li, et al.. (2011). Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population. Hepatology. 55(3). 709–719. 75 indexed citations
13.
Doi, Hiroyoshi, Kazuo Konishi, Atsushi Katagiri, et al.. (2011). Primary micropapillary carcinoma of the colon: a case report and literature review. Clinical Journal of Gastroenterology. 4(2). 99–103. 2 indexed citations
14.
Sakaki, Masashi, Reiko Makino, Kazumasa Hiroishi, et al.. (2010). Cyclooxygenase‐2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression. Hepatology Research. 40(12). 1219–1226. 22 indexed citations
15.
Hiroishi, Kazumasa, et al.. (2010). Immune Response of Cytotoxic T Lymphocytes and Possibility of Vaccine Development for Hepatitis C Virus Infection. SHILAP Revista de lepidopterología. 2010. 1–10. 9 indexed citations
16.
Hiroishi, Kazumasa, Junichi Eguchi, Toshiyuki Baba, et al.. (2009). Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma. Journal of Gastroenterology. 45(4). 451–458. 110 indexed citations
17.
Doi, Hiroyoshi, Kazumasa Hiroishi, Tomoe Shimazaki, et al.. (2008). Magnitude of CD8+ T‐cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection. Hepatology Research. 39(3). 256–265. 5 indexed citations
18.
19.
Doi, Hiroyoshi, et al.. (1995). [Posterolateral extradural approach for total excision of spinal meningeal cyst (type Ia): case report].. PubMed. 23(4). 339–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arjan Boltjes Breakdown of academic impact, for papers by Amir Gander Breakdown of academic impact, for papers by Ahmed Eid Breakdown of academic impact, for papers by Tsuneaki Tagaya Breakdown of academic impact, for papers by Kiyoshi Furuta Breakdown of academic impact, for papers by Hideko Nuriya Breakdown of academic impact, for papers by Shijun Chen Breakdown of academic impact, for papers by Sarah Goddard Breakdown of academic impact, for papers by Michelle Chung Breakdown of academic impact, for papers by Yuejiao Dong
Rankless by CCL
2026